tirscollaborate.wordpress.com
Collaborate to Innovate | Official blog of DIA Publications | Page 2
https://tirscollaborate.wordpress.com/page/2
Official blog of DIA Publications. Newer posts →. DIA’s Global Forum: Driving Ideas to Action. April 14, 2015. The April issue of DIA’s. Online magazine is now available at http:/ globalforum-online.org. In this issue, experts take a deep dive look into several of the trends to watch from DIA’s What Lies Ahead. Report which was released in February. The April issue is the first in our new reader-friendly and content-rich format, featuring fresh perspectives from industry experts. Continue reading →.
tirscollaborate.wordpress.com
DIA’s Global Forum: Driving Ideas to Action | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/04/14/dias-global-forum-driving-ideas-to-action
Official blog of DIA Publications. What Lies Ahead 2015: Trends to Watch. In Case You Missed It: April Global Forum Looks at Industry Trends Across the Globe →. DIA’s Global Forum: Driving Ideas to Action. April 14, 2015. The April issue of DIA’s. Online magazine is now available at http:/ globalforum-online.org. In this issue, experts take a deep dive look into several of the trends to watch from DIA’s What Lies Ahead. Edith Frénoy, of EFPIA, examines the trend from a European perspective in The Rising ...
tirscollaborate.wordpress.com
What Lies Ahead 2015: Trends to Watch | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/04/08/what-lies-ahead-2015-trends-to-watch
Official blog of DIA Publications. Join Us in Paris for DIA’s Flagship European Offerings. DIA’s Global Forum: Driving Ideas to Action →. What Lies Ahead 2015: Trends to Watch. April 8, 2015. Have you seen DIA’s What Lies Ahead 2015 report yet? The third annual report was released earlier this year, providing experts’ insights into the year ahead for pharmaceuticals, biotechnology and medical devices. To read the full report, click here. In the upcoming April issue of DIA’s. Let us know in the comments.
tirscollaborate.wordpress.com
The FDA’s Quality Revolution | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/07/14/the-fdas-quality-revolution
Official blog of DIA Publications. The FDA’s Quality Revolution. July 14, 2015. By Peter J. Pitts. Let it be said that the spark that ignited the flame was when FDA leadership asked, Do we know enough about the quality of drugs that are sold in the United States. So said, CDER Director Dr. Janet Woodcock during yesterday’s webinar,. Understanding CDER’s Super Office Of Pharmaceutical Quality and Its Effect on You. Janet is the acting director of the OPQ and Lawrence is the acting deputy.). Since there is...
tirscollaborate.wordpress.com
The Globetrotting Regulator | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/05/27/the-globetrotting-regulator
Official blog of DIA Publications. Message from DIA 2015 51st Annual Meeting Program Co-Chair Dr. Michael Rosenblatt. The FDA’s Quality Revolution →. May 27, 2015. By Peter J. Pitts. I am putting in a lot of miles on behalf of international regulatory fraternity. At the top of the list is quality. In April I spent three fascinating days in Sharm El Sheikh, Egypt at the Second Arab Conference on Food and Drugs. It was all business and I didn’t even mind not getting any time to enjoy the Red Sea beaches.
tirscollaborate.wordpress.com
In Case You Missed It: April Global Forum Looks at Industry Trends Across the Globe | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/04/27/in-case-you-missed-it-april-global-forum-looks-at-industry-trends-across-the-globe
Official blog of DIA Publications. DIA’s Global Forum: Driving Ideas to Action. Disruptive Innovation in Health Care →. In Case You Missed It: April Global Forum Looks at Industry Trends Across the Globe. April 27, 2015. Have you read the April issue of. Featuring a new look, and in-depth content from an expanded editorial board, this issue is available open access (no log in required) at www.globalforum-online.org. Dr Ling Su and Fuyu Song offered their take on What Lies Ahead in China. How do you see t...
tirscollaborate.wordpress.com
Disruptive Innovation in Health Care | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/04/29/disruptive-innovation-in-health-care
Official blog of DIA Publications. In Case You Missed It: April Global Forum Looks at Industry Trends Across the Globe. Message from DIA 2015 51st Annual Meeting Program Co-Chair Dr. Michael Rosenblatt →. Disruptive Innovation in Health Care. April 29, 2015. Discussing these challenges is a distinguished panel at the DIA 2015 51. Disruptive Forces in Health Care Innovation: Where Are They Leading Us? The panel is chaired by Jeffrey Kasher, PhD, President, Patients Can’t Wait, LLC. Joining Dr. Kas...Inven...
tirscollaborate.wordpress.com
Message from DIA 2015 51st Annual Meeting Program Co-Chair Dr. Michael Rosenblatt | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/05/22/message-from-dia-2015-51st-annual-meeting-program-co-chair-dr-michael-rosenblatt
Official blog of DIA Publications. Disruptive Innovation in Health Care. The Globetrotting Regulator →. Message from DIA 2015 51st Annual Meeting Program Co-Chair Dr. Michael Rosenblatt. May 22, 2015. Gathering in Washington, DC, is the perfect place to pursue our shared mission to improve health and well-being, and to learn how to be great partners in drug development from each other. To that end, I am honored to serve as Program Co-Chair of the DIA 2015 51. The DIA 2015 51. Gives us a special place and...
tirscollaborate.wordpress.com
Whither Off-Label? | Collaborate to Innovate
https://tirscollaborate.wordpress.com/2015/08/13/whither-off-label
Official blog of DIA Publications. The FDA’s Quality Revolution. Towards a More Intramural Approach to Biomarker Development →. August 13, 2015. By Peter J. Pitts. The debate over off-label communications doesn’t begin or end with the Caronia or Amarin decisions. It’s a continuing dialogue between manufacturers and the FDA, between doctors and patients, between doctors and academics, between lawyers and judges, and between advocates on all sides. But who is the leader and who is the follower? Off-label c...
